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Abstract
Background: The effects of physical activity on prescription (PAP) on health-related quality of life (HRQoL) in overweight
adults are unclear. We therefore aimed to explore the effects of the Swedish PAP model on HRQoL in overweight older
adults.
Methods: Participants were recruited from a cohort of men and women born between 1937 and 1938, and living
in Stockholm County. Inclusion criteria were; insufficiently physically active, i.e. <30 min of at least moderate
intensity physical activity (PA) per day; body mass index >25 kg/m2; and waist circumference ≥102 cm (men)
or ≥88 cm (women). Altogether, 101 individuals, aged 67 years, were randomly assigned to two parallel groups:
intervention group (n = 47) receiving individualised PAP or control group (n = 54). The 36-item Short Form Health
Survey (SF-36) was administered before and after the six months intervention. Main outcomes were the SF-36
physical component summary (PCS) and mental component summary (MCS) scores. Intention to treat analysis
was utilised. Regression analysis was performed to assess whether changes in PA and body weight affected
changes in HRQoL.
Results: At the six months follow-up, regarding the MCS score, the intervention group had improved significantly
more (median: 4.4 [interquartile range (IQR): −2.4 to 23.3]) vs (median: 0.0 [IQR: −4.0 to 4.9]); p < 0.05) and a higher
proportion of participants had attained relevant improvements (OR 2.43 (95 % CI 1.00–5.88) p < 0.05) compared to
the controls. A within group improvement in the PCS score (median: 3.8 [IQR: −1.9 to 19.5] p < 0.05) was found in
the intervention group. Changes in PA and body weight had a small, but significant, mediating effect on the
changes in HRQoL.
Conclusions: PAP had a positive effect on HRQoL, measured by the SF-36 MCS, but no significant between group
effect was seen on the PCS in overweight older adults. These effects were, to some extent, mediated by changes
in PA and body weight. Our findings support clinical use of the Swedish PAP model.
Trial registration: ClinicalTrials.gov NCT02320760.
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Background
Physical activity (PA) is beneficial for promotes health
across all age categories. However, the level of PA de-
creases with age, particularly after age 65 [1]. The preva-
lence of lifestyle diseases also increase with age. This
causes subsequent decreases in health related quality of
life (HRQoL), an important measure of burden of disease.
The Centers for Disease Control and Prevention describe
HRQoL as “a broad multidimensional concept that usu-
ally includes self-reported measures of physical and mental
health” [2]. Due to increased mean life expectancy we
need to ascertain HRQoL throughout the extended older
adulthood. Both positive effects [3–5], and limited evi-
dence or absence of effects [6–11], of PA on HRQoL in
older adults are reported from randomised controlled
trials (RCT). However, heterogeneity in methods and
measured HRQoL domains complicate the interpret-
ation [10, 12].
Different models for prescribed PA exist internationally
and have shown varying degree of efficacy. A difficulty lies
in reviewing the effect of different models because they are
of different constructs, provided to different populations or
patient cohorts in different sociocultural environments. Re-
cent systematic reviews unanimously concluded that there
is insufficient evidence to recommend Exercise Referral
Schemes (ERS) over advice or counselling interventions
[13–15]. Nevertheless, further scientific evaluation is called
for in these reviews. There are different prescribed PA
models from Denmark [16], the Netherlands [17], and
Finland [18] and they all, just like the ERS’, vary in construct
to some extent. The Swedish physical activity on prescrip-
tion (PAP) model has five components: (a) patient-centred
counselling, (b) written prescription of individualised
PA using (c) the text book FYSS (Physical Activity in
the Prevention and Treatment of Disease) for evidence-
based prescriptions [19], (d) follow-up assessments,
and (e) collaboration with societal organisations [20]. A
good summary of the model is given by Raustorp and
Sundberg [21].
The Swedish PAP model has been shown to increase
PA and improve HRQoL in a heterogeneous patient co-
hort [22], and in hypertensive patients [23] and to re-
duce cardiovascular risk factors without decreasing
HRQoL in healthy men aged 35–60 years [24]. However,
further scientific evaluation of effects on HRQoL of the
Swedish PAP model is needed as the literature is scarce
[25]. Additionally, evaluation of the effects on health of
different models for prescribing PA is needed as the
international literature is inconclusive [13–18].
The study at hand reports secondary outcomes from a
RCT of which the primary aim was to assess the effect
of the Swedish PAP on the level of PA in overweight
older adults with abdominal obesity. PA and body weight
improved significantly in favour of the participants who
received PAP. These results are reported in detail else-
where [26, 27]. It was hypothesised, a priori, that the
Swedish PAP could have a direct effect on HRQoL, and
a posteriori, that such an effect could be mediated by
changes in PA and body weight. Further, to our knowledge,
no RCT to examine the effect of the Swedish PAP model
on HRQoL has been published. The objective of this study
was therefore to examine the effect of the Swedish PAP
model, and the influences of changes in PA and body
weight, on HRQoL in overweight older adults.
Methods
Participants
Participants were recruited from a cohort of Stockholm
County citizens born between 1937 and 1938 who had
taken part in a health screening survey (n = 4232) [28].
Inclusion criteria were: healthy but insufficiently physic-
ally active (<30 min of at least moderate intensity PA per
day), a body mass index (BMI) between 25 and 40 kg/m2
and waist circumference ≥102 cm (men) or ≥88 cm
(women). Exclusion criteria included self-reported pharma-
cological treatment for hypertension, hyperlipidaemia, type
2-diabetes, or serious chronic disease. The proportion of
older people (>65 years) in the population is increasing
worldwide. Because most chronic diseases manifest later in
life and PA decreases with age, it is urgent to develop and
evaluate methods for promoting PA and HRQoL in the eld-
erly. The rationale for the inclusion criteria was therefore to
reach an older (>65 years) group with insufficient levels of
PA, overweight and abdominal obesity.
In 2005, an invitation and a pre-screening question-
naire were sent to 407 individuals who had met the in-
clusion criteria during the initial screening in the late
1990s. Out of the 246 participants who agreed to take
part in the present study, 116 met the inclusion criteria
after the screening process. Fifteen of these participants
were excluded before randomisation due to migration,
death, or serious acute illness (Fig. 1).
Design
The six months blinded RCT was conducted at the
Obesity Unit of the Karolinska University Hospital in
Huddinge, Sweden. The intervention group received treat-
ment according to the Swedish PAP model [20, 27],
and the control group received general written advice
on PA and health. Randomisation sequence was superim-
posed on the calendar days of the baseline assessments to
prevent social interaction between participants in the
two groups. The staff delivering the intervention
could not be blinded to group allocation. Measure-
ments were performed just before (baseline) and right
after the six months intervention (follow-up), and in-
cluded pedometry, anthropometrics, a venous blood
sample, blood pressure, PA diary [26, 27], and a
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questionnaire (hereby referred to as the questionnaire).
The questionnaire contained items regarding demograph-
ics, lifestyle, health, PA, food habits, morbidities, and
problems that inhibit everyday tasks, social interaction,
and sex life. The SF-36 and the item regarding sitting time
from the last 7-day short form International Physical
Activity Questionnaire (IPAQ) were also included in
the questionnaire.
Fig. 1 Flowchart of all participants from the screening to the six month follow-up. Note: PAP = Physical activity on prescription. *Intention to treat
analysis with last observation (baseline) carried forward for participants that did not provide follow-up data (n = 2), and single missing data points
at follow-up (each SF-36 item counting as data point)
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The intervention
For ethical reasons, the control group received one page
of general written information about the importance of
PA for health. The control group were not supported in
any other way regarding PA behaviour during the course
of the trial. The intervention group received treatment
according to the Swedish PAP model [26, 27] in addition
to the same written information the control group re-
ceived. Directly after the baseline assessments, a phys-
ician briefly raised the question of increased PA for
health with each participant. This was followed by
30 min of individualised patient-centred counselling,
resulting in a prescription for PA by a health-care pro-
fessional trained in motivational counselling for PA, The
participants received one counselling session each dur-
ing the trial. The PAP counselling was individually tai-
lored and encompassed an agreement for increasing PA
including individual goals, which were summarised and
written on a prescription form. Each individualised writ-
ten prescription included the specified modality of PA,
intensity, frequency and duration of the different activ-
ities, and the rational for the PAP. All participants were
encouraged to gradually increase their PA level to meet
the recommended level of PA, i.e. accumulate 30 min or
more of at least moderate intensity PA on most, prefera-
bly all, days of the week and include both aerobic and
strength training, as well as exercise for improved flexi-
bility and balance [29]. They were also encouraged to
decrease their time spent being sedentary. Within one
month of the baseline assessments, a 60 min group ses-
sion was held with the intervention group. It included a
lecture by a physician regarding PA and health and time
for discussion and questions. Each person in the inter-
vention group received a letter from the physician, with
individualised advice on increase of PA, based on the
baseline assessments. All intervention group participants
knew that there would be a follow-up PAP counselling
session after the six months assessments. The theoretical
framework for the intervention was based on social cog-
nitive theory, the transtheoretical model, motivational
interviewing and supportive environment [30–33]. The
counselling provided was adjusted to each participant’s
readiness to change.
Quality of life
The 36-item Short Form Health Survey (SF-36) (IQOLA
SF-36 Standard Swedish Version 1.0) was part of the
questionnaire. It consists of 36 items used to score eight
scales: limitations in physical activities because of health
problems (physical functioning), limitations in usual role
activities because of physical health problems (role phys-
ical), bodily pain, general health perceptions (general
health), energy and fatigue (vitality), limitations in social
activities because of physical or emotional problems
(social functioning), limitations in usual role activities
because of emotional problems (role emotional), and
psychological distress and well-being (mental health).
Two summary measures, the physical component sum-
mary (PCS) and the mental component summary
(MCS), are derived from the first and last four scales, re-
spectively [34–38]. The SF-36 is the most extensively
validated and used generic tool for measuring HRQoL,
including among older adults [12, 39, 40]. The SF-36
data were handled and scored following previously pub-
lished instructions [38]. All scores range from 0 to 100,
representing the worst and best possible score. The
minimum value for a clinically important improvement in
the >SF-36 scores was identified as a baseline value <88
and follow-up value ≥88 (hereby referred to as “change
to top-score”). This method identifies those that re-
spond with the maximum score on the majority, or all,
of the ordinal scales corresponding to a certain SF-36
score. It is possible to score less than maximum on
half, or more, of the ordinal scales and still achieve a
SF-36 score larger than 88 regarding bodily pain, vital-
ity, and mental health; therefore, in these cases, the
change to top-score method is not, theoretically, valid.
The change to top-score method is inspired by the
work of Velanovich [41], and Spratt [42]. Velanovich
argued that becauseSF-36 data are very often not nor-
mally distributed, and left skewed, and the SF-36 scores
are derived from ordinal scales ranging from two to six
grades, appropriate statistical techniques should be
used. The traditional normalisation of the SF-36 data,
i.e. converting the ordinal scales to a scale of 1 – 100,
does not guarantee a normal distribution. Therefore, in
cases when the mode and the median are both at max-
imum score, i.e. 100, Velanovich has suggested using
the difference in proportions of individuals scoring 100
to enable group comparisons [41]. However, Velanovich
did not suggest any methods for evaluating individual
changes in SF-36 scores. According to Spratt a minimal
clinically important difference (MCID) must be larger
than the standard error of measurement and have clin-
ical relevance. Regarding the SF-36 score for physical
functioning, Spratt found the standard error of meas-
urement ranged from 5 to 20 at six month follow-up,
and a cut-off of 85 to be useful for determining a clinic-
ally important improvement [42]. Bjorner et al. have
found that a ≥10 point decrease in SF-36 vitality score
was significantly associated with increased odds of negative
outcomes such as hospitalisation, and mortality. However,
changes in SF-36 were not compared to positive health out-
comes [43], and the ≥10 point decrease cut-off lies within
the range of SF-36 standard error of measurement found
by Spratt [37, 42]. Further, the standard error of measure-
ment ranged from 12 to 17 in Swedish normative popula-
tion data for men and women 65 – 69 years old [37, 38].
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Therefore, to enable analysis of clinically significant changes
in the SF-36 scores bodily pain, vitality, and mental health,
we used a >20 point change in SF-36 scores as a marker of
a MCID in individuals from baseline to follow-up (hereby
referred to as ‘>20 point improvement’).
Physical activity and sedentary behaviour measures
The Yamax Digiwalker SW-200 pedometer (Yamax
Corporation, Tokyo, Japan) [44, 45] was used to meas-
ure daily steps and the participants were instructed to
wear it at all times for seven consecutive days, except
when sleeping, bathing, or showering. The participants
were instructed to register daily steps in a pre-printed
seven day PA diary at baseline and follow-up assess-
ments. In this diary they also registered frequency and
duration of all physical activities, which were self-rated
according to Borg’s Rate of Perceived Exertion (RPE)
scale, ranging from 6 (no exertion at all) to 20 (max-
imal exertion imaginable) [46]. Oral instructions on
how to use the diary and Borg’s RPE scale [47] were
given individually to all participants, who also prac-
ticed, under supervision, using the Borg scale while
cycling on an ergometer. The intensity of PA was later
categorised as “light” (RPE 10–11), “moderate” (RPE
12–13), or “vigorous” (RPE ≥14) [48]. At baseline and
follow-up assessments all participants were asked to
complete the questionnaire. Time per day spent sitting
was assessed with an item from the last 7-day short
form IPAQ, which was part of the questionnaire [49]. A
validated question for leisure time PA during the last
12 months was also part of the questionnaire, and in-
cluded four categories ranging from sedentary leisure
time (<2 h of light PA/week) to regular exercise (≥3
times/week, ≥30 min each time) [50].
Statistical analysis
All statistical calculations were performed using STA-
TISTICA 11 (StatSoft, Inc., Tulsa, OK, USA). An alpha
level of 0.05 was used to determine statistical signifi-
cance. Normality was assumed if a Lilliefors corrected
Kolmogorov-Smirnov test and a Shapiro-Wilk test gen-
erated non-significant results, z-scores of skewness and
kurtosis were within zero +/− 1.96 standard error of the
respective statistics. An intention to treat approach,
where missing data (i.e. single missing data points at
follow-up or when a participant had not taken part of
the follow-up assessments at all (n = 2)) was replaced by
last observation carried forward, was used. A Wilcoxon
matched pairs test was used to analyse differences in the
SF-36 scores between baseline and follow-up within each
group. Mann–Whitney U Tests were used to analyse dif-
ferences between the intervention and control group in
the SF-36 scores at baseline, and in changes in the SF-36
scores from baseline to follow-up. Nonlinear logit
regression models were used to analyse differences be-
tween the intervention and control group in proportions
of participants who displayed a clinically relevant change
in the SF-36 scores from baseline to follow-up. Beneficial
intervention effects on level of PA and overweight have
previously been reported, regarding the study at hand
[26, 27]. Additional regression models, where the PA
and body weight variables were entered, stepwise, to test
for possible influences on the hypothesised intervention
effects on HRQoL, were therefore used. Cohen’s kappa
was calculated as a measure of agreement between the
two methods (‘change to top-score’ and ‘>20 point
change’) for classifying individual increases in the SF-36
scores as clinically significant. This comparison was ap-
propriate because the ‘change to top-score’ method is a
modification of other novel methods, and the ‘>20 point
change’ method is a more traditional method based on
the standard error of the measurement. While the
current study reports on secondary outcomes it was
powered according to the primary aim. A priori sample
size calculation showed that 70 individuals per group
was sufficient to detect a group difference of 1.5 cm in
change in waist circumference, with a statistical power
of 80 % and alpha of 0.05.
Ethical considerations
Ethical approval was obtained from Stockholm
Regional Ethical Review Board (04-520/2) and all par-
ticipants provided written informed consent prior to




The final study population consisted of 101 individuals
who in 2006, aged 67 to 68 years, were randomised to the
intervention (n = 47, 57 % women) or control (n = 54,
57 % women) group. There were no significant differences
between the intervention and control group at baseline re-
garding anthropometrics, PA according to pedometry or
self-report, sitting time and HRQoL, except for the SF-36
scale general health (diff = 10, p < 0.05, power = 0.62), in
which the intervention group scored significantly lower
than the control group (Tables 1 and 2). The frequency of
participants scoring 88 or higher in the SF-36 scores at
baseline did not differ significantly between the interven-
tion and control group (Table 3). The flow of participants
through the trial is depicted in Fig. 1 and baseline charac-
teristics are described in Table 1.
Quality of life
None of the SF-36 scores met the assumptions of nor-
mality and all were left skewed, i.e. the scores were con-
centrated in the ≥88 “top-score” (see proportions in
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Table 3), thus non-parametric statistical methods were
used. The intervention group improved significantly from
baseline to follow-up in the scale general health (diff =
10, p = 0.03, power = 0.57), the PCS (diff = 3.8, p < 0.02,
power = 0.35) and MCS (diff = 4.4, p = 0.02, power =
0.23). The control group displayed no significant changes
from baseline to follow-up. The intervention group im-
proved significantly more in the MCS (diff = 4.4, p = 0.03,
power = 0.15) and displayed higher proportions of
participants with relevant improvements in the role emo-
tional scale (diff = 19 %, p < 0.02, power = 0.67) and MCS
(diff = 18 %, p < 0.05, power = 0.52), in comparison to the
control group.
The assumption of normality was not met for change
in steps per day, body weight, PA of at least moderate
intensity in sessions per week and in minutes per week,
leisure time PA, as well as the changes in the SF-36
scores. We found change in body weight and change in
self-reported leisure time PA to be the only delta vari-
ables fit for inclusion in the regression analysis. The
delta PA and delta body weight variables were entered,
stepwise, in the non-linear logit regression models to
test for possible influences on clinically relevant changes
in SF-36 scores. An increase in body weight and a de-
crease in leisure time PA had a statistically significant
positive influence on the proportion of participants that
exhibited a clinically relevant improvement in the SF-36
scores vitality, role emotional, and MCS.
Discussion
The main finding from this study is that the Swedish
PAP improved HRQoL, assessed by the SF-36 MCS,
among older adults with abdominal obesity. These ef-
fects were, to some extent, mediated by changes in PA
and body weight.
The group receiving PAP displayed beneficial changes in
the SF-36 MCS and PCS scores from baseline to follow-
up. The control group exhibited no such changes. The
intervention group improved more than the control group
in the scale Role emotional and the MCS, assessed as
number of cases showing a relevant improvement. These
findings are in line with studies on prescribed PA, includ-
ing an uncontrolled study of the Swedish PAP [22]. In five
Danish programs, exercise on prescription led to HRQoL
Table 1 Baseline characteristics regarding physical activity, body





Sex (female/male (percent female)) 27/20 (57 %) 31/23 (57 %)
Steps per day, pedometry 5390 (2791) 4980 (2763)
Body weight (kg) 88 (14.2) 88.3 (11.1)
Physical activity diary
Sessions/week of at least moderate
intensitya
2 (1–5) 2 (1–5)
Minutes/week of at least moderate
intensitya
120 (0–220) 130 (40–215)
Questionnaire
Sitting time (hours/day) 5 (3–7) 5 (4–7)
Leisure time physical activity
Sedentary leisure time 13 % 11 %
Light activities ≥2 h/week 64 % 59 %
Regular moderate PA 1 to
2 · ≥30 min/week
15 % 20 %
Regular exercise ≥3 ·≥30 min/week 4 % 9 %
Follow-up data unavailable (n) 2 0
Note: All data expressed as mean (SD), median (Q1–Q3), number or percentage
aDefined as rate of perceived exertion (RPE) ≥12 [46–48]
Table 2 SF-36 baseline, follow-up and delta values and group differences
Intervention Control
Variable Baseline Follow-up Delta Baseline Follow-up Delta p
Physical functioning 85 (70–90) 88 (70–95) 0.0 (−8.3–10.0) 85 (70–94) 90 (80–95) 1.9 (−5.0–14.4) 0.58
Role physical 100 (75–100) 100 (100–100) 0.0 (0.0–25.0) 100 (75–100) 100 (75–100) 0.0 (−25.0–0.0) 0.15
Bodily pain 78 (75–100) 90 (58–100) 0.0 (−10.0–22.5) 78 (58–100) 79 (60–100) 0.0 (−12.5–20.0) 0.57
General health 70 (58–90)* 78 (65–85) 10.0 (−5.0–20.0)† 80 (65–85)* 80 (70–90) 0.0 (−10.0–15.0) 0.26
Vitality 63 (50–85) 75 (65–85) 5.0 (−10.0–30.0) 75 (65–85) 75 (65–90) 0.0 (−10.0–10.0) 0.10
Social functioning 100 (88–100) 100 (100–100) 0.0 (0.0–12.5) 100 (100–100) 100 (100–100) 0.0 (−0.0–0.0) 0.22
Role emotional 100 (67–100) 100 (100–100) 0.0 (0.0–33.3) 100 (100–100) 100 (100–100) 0.0 (−0.0–0.0) 0.08
Mental health 80 (64–92) 88 (76–96) 4.0 (−8.0–28.0) 90 (72–96) 88 (72–92) 0.0 (−8.0–8.0) 0.17
PCS 80 (67–88) 86 (76–90) 3.8 (−1.9–19.5)† 83 (73–90) 84 (69–92) 0.0 (−11.3–10.6) 0.12
MCS 84 (70–94) 90 (83–95) 4.4 (−2.4–23.3)† 89 (83–94) 89 (78–94) 0.0 (−4.0–4.9) 0.03
Note: Data expressed as median (Q1–Q3). P-values refer to the difference between intervention and control groups in delta SF-36, i.e. change from baseline to
follow-up (Mann–Whitney U Test). PCS = physical component summary, MCS =mental component summary
*p < 0.05 regarding group difference at baseline (Mann–Whitney U Test)
†p < 0.05 regarding change from baseline to follow-up within groups (Wilcoxon matched pairs test)
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improvements in 10 %–33 % of the participants [16], and
in New Zealand prescribed PA has been shown to increase
PA and HRQoL among inactive women [51].
Favourable intervention effects on the level of PA and
overweight, regarding the study at hand, have previously
been reported by Kallings and colleagues [26, 27]. Body
weight, BMI, neck circumference and fat mass improved
significantly in favour of the intervention group. In the
current study body weight correlated strongly with, and
gave almost identical results as, the other weight related
measures. Body weight was therefore used as a proxy for
these measures to minimise multiple testing. Somewhat
surprisingly, the results in the study at hand show that de-
creases in self-reported leisure time PA, and increases in
body weight, facilitated clinically relevant improvements in
HRQoL. This is a conflicting finding because we hypothe-
sised that an increase in PA and decrease in body weight
would facilitate positive effects on HRQoL. However, there
are several reasons to be cautious when interpreting these
findings. First, the correlations between the delta PA, delta
body weight, and delta SF-36 variables were mostly very
weak and non-significant (not reported). Second, the Wald
statistic (not reported) indicated that the contribution of
each of these two predictors were small, and non-
significant, and the regression models only improved if
both of these covariates were included. Delta PA and delta
body weight only had an effect in the already significant
regression models. It could be that the present study was
not powered to detect confounding effects. Further, pedom-
eters, diaries and questionnaires are imprecise tools for
measuring, foremost, intensity and duration of PA;
therefore, we may have missed some actual changes in PA
masking a stronger relationship with changes in HRQoL.
Another possible explanation is the fact that some partici-
pants scored very high in some of the SF-36 scores at base-
line, thus decreasing the likelihood of a clinically significant
improvement, or improvements per se, at follow up.
There are several different determinants of HRQoL on an
individual level, such as physical and mental health percep-
tions, functional status, social support [2], and intra- and
interpersonal changes triggered by treatment and group
support [52]. Such factors may be part of the mechanisms
behind our results.
Despite trials such as the current one demonstrating that
Swedish PAP has an effect on HRQoL, the true effect size
may be underestimated. For instance, the placebo and
Hawthorne effects could have an impact on the results re-
ported here, masking a larger true effect [30]. On the con-
trary, practitioners in a regular clinical setting might not
deliver Swedish PAP with the same confidence or emphasis
as in this trial, which may lead to a smaller true effect. The
latter seems less likely when comparing the present study
to an uncontrolled study, conducted within the Swedish
health care system [22]. That study presented significant
Table 3 Proportions per group, and odds ratios regarding clinically relevant improvements in SF-36 variables
Variable Intervention (n = 47) Control (n = 54) Change to top-scoreA >20 point improvement
SF-36 score <88




at BL (n (%))
ImprovedA
(n (%))
OR (95 % CI)B OR (95 % CI)B Cohen’s kappaC
Physical functioning 28 (60 %) 10 (21 %) 36 (67 %) 16 (30 %) 0.64 (0.26–1.60) 1.17 (0.32–4.31) 0.79
Role physical 16 (34 %) 13 (28 %) 14 (26 %) 9 (17 %) 1.91 (0.73–5.00) 1.68 (0.67–4.30) 0.99
Bodily pain 26 (55 %) 11 (23.5 %) 31 (57 %) 12 (22 %) 1.07 (0.42–2.71) 1.34 (0.55–3.24) 0.87
General health 39 (83 %) 6 (13 %) 41 (76 %) 15 (28 %) 0.38 (0.13–1.08) 1.14 (0.42–3.11) 0.82
Vitality 39 (83 %) 7 (15 %) 42 (78 %) 8 (15 %) 1.01 (0.34–3.02) 4.32 (1.29–14.55)* 0.85
5.03 (1.42–17.85)*D
Social functioning 14 (30 %) 12 (25.5 %) 13 (24 %) 7 (13 %) 2.30 (0.82–6.45) 2.98 (0.72–12.24) 0.89
Role emotional 15 (32 %) 14 (30 %) 11 (20 %) 6 (11 %) 3.39 (1.18–9.74)* 2.85 (1.04–7.83)* 0.99
4.25 (1.37–13.16)*D 3.46 (1.17–10.23)*D
Mental health 26 (55 %) 10 (21 %) 25 (46 %) 10 (19 %) 1.19 (0.45–3.17) 2.30 (0.82–6.45) 0.86
PCS 38 (81 %) 10 (21 %) 34 (63 %) 9 (17 %) 1.35 (0.50–3.67) 1.70 (0.61–4.79) 0.83
MCS 29 (62 %) 18 (38 %) 25 (46 %) 11 (20 %) 2.43 (1.00–5.88)* 5.88 (1.54–22.42)** 0.83
2.82 (1.09–7.33)*D 8.24 (2.03–33.49)**D
Note: OR: Odds ratio; PCS: physical component summary; MCS: mental component summary
AChange to top-score: a baseline value <88 and follow-up value ≥88
BNonlinear logit regression with ‘change to top-score’ or ‘>20 point improvement’ as dependent variable and group allocation as independent variable
CAgreement between the ‘change to top-score’ and ‘>20 point change’ classification methods in regard to the proportions of participants displaying clinically
significant improvements in the SF-36 scores
DChange in body weight and self-reported leisure time physical activity as continuous covariates (only reported when these two covariates had a significant
impact on the OR)
*p < 0.05
**p < 0.01
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increases in all but one of the SF-36 domains, while the
present controlled study only identified effects on two of
the SF-36 domains. Thus, the true effect of Swedish PAP
on HRQoL may possibly be larger than reported here.
There are some limitations to this study. It was not
statistically powered based on the self-report outcomes.
HRQoL is often applied as a secondary outcome meas-
ure in exercise trials [39], and this study is no exception.
Available sample size calculations based on normative
Swedish data (power = 0.80, alpha = 0.05) show that the
sample size in this study is sufficient to detect a 20-point
between group difference at follow-up, and a 10-point
difference between baseline and follow-up within
groups, for all SF-36 scores, and a 10-point between
group difference at follow-up for the scores physical
functioning, general health, vitality, social functioning,
and mental health [38]. The statistical power obtained
regarding the results in the present study ranged from
weak (0.15) to moderate (0.62). Low statistical power is
thus a limitation in this study. A cut-off of 88 was
chosen to determine a relevant change in the SF-36 and
was inspired by the work of Velanovich [41], and Spratt
[42]. However, as Spratt points out, the clinical import-
ance of change is related to several factors, such as base-
line score, age, gender, tobacco and alcohol use,
medications, mood, and how well the patient can com-
ply with the treatment. We consider the methods used
in the study at hand conservative, and the SF-36 cut-off
of 88 an appropriate indicator of a clinically significant
change. The intention to treat approach had a more
conservative impact on the results compared to simply
excluding cases with missing data from analysis. Still,
this may limit interpretation of the results. The SF-36
scale for general health differed significantly between the
groups at baseline, which indicates a risk for regression
to the mean. However, the delta values for general health
did not differ significantly between the two groups, and
we found no intervention effect on general health. Thus,
regression to the mean does not seem to have affected
the results.
Compared to Swedish normative data available for 65
to 69 year old men and women (n = 517) [38] our study
sample had significantly higher mean scores for role
physical (diff = 12, p < 0.001), and general health (diff = 5,
p < 0.5), but did not differ for the other six SF-36 scores
(PCS and MCS not included in the normative data base).
Further, the participants in the present study were re-
cruited from a larger randomly selected population
sample. Thus, we consider our sample to be fairly rep-
resentative of the Swedish population for this age group
in regard to HRQoL.
Future studies evaluating the effect of PAP on HRQoL
should be powered to detect clinically relevant changes
and set HRQoL as a primary outcome. It is of importance
to choose the most appropriate method, out of several
available, for handling and statistically analysing SF-36
data. Objectively measured aspects of PA other than just
steps per day, such as the use of accelerometers, may add
quality.
Conclusion
The Swedish Physical Activity on Prescription model
may have a positive effect on mental aspects of HRQoL
measured by the SF-36 among older men and women
with abdominal obesity. The changes in HRQoL oc-
curred independently of changes in PA, body weight,
and sedentary behaviour. These findings support the
clinical use of the Swedish PAP model.
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